Linus Biotechnology

Curated by Signal

Developer of diagnostic tests for central nervous system and gastrointestinal disorders

Overview

Developer of diagnostic tests for central nervous system and gastrointestinal disorders. The company offers StrandDx ASD, a non-invasive diagnostic aid for Autism Spectrum Disorder. The company's pipeline comprises precision exposome medicine biomarkers and target discovery across gastroenterology, renal disease and oncology.

Key facts

Founded: 2020
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Agile Health
Mobile app for behavior modifications to improve disease conditions for chronic disease patients
Health TechnologyLincolnshire, United States
Med Spa Communications
Virtual receptionist and call answering service for medical spas and aesthetic practices
Health TechnologyBoca Raton, United States
Pearl
Provider of software solutions for fertility & pregnancy tracking
Health TechnologyClaymont, United States

About Linus Biotechnology

What does Linus Biotechnology do?

Developer of diagnostic tests for central nervous system and gastrointestinal disorders.

Where is Linus Biotechnology headquartered?

Linus Biotechnology is headquartered in New York City, United States.

When was Linus Biotechnology founded?

Linus Biotechnology was founded in 2020.

Which sector is Linus Biotechnology in?

Linus Biotechnology operates in Health Technology.

Who are Linus Biotechnology's competitors?

Companies similar to Linus Biotechnology include Agile Health, Med Spa Communications, and Pearl.